{"id":605519,"title":"Notice: Prescription Drug List (PDL): Hyoscine butylbromide - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T01:09:43.906000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-hyoscine-butylbromide.html","snippet":"Notice: Prescription Drug List (PDL): Hyoscine butylbromide February 12, 2016 Our file number: 16-101454-524 The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch injectable Hyoscine butylbromide to prescription…","rawSnapshotUrl":"/api/snapshots/raw/605519","browseUrl":"https://replay.healtharchive.ca/job-6/20260306010943/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-hyoscine-butylbromide.html#ha_snapshot=605519","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}